Telix Pharmaceuticals Limited - American Depositary Shares (NQ:TLX)
9.340
-0.170
(-1.79%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 14, 2025
Add to My Watchlist
All News about Telix Pharmaceuticals Limited - American Depositary Shares
Illuccix® Approved in the United Kingdom
February 12, 2025
Via GlobeNewswire
Telix Completes Acquisition of RLS (USA) Inc.
January 27, 2025
Via GlobeNewswire
Illuccix® Receives European Approval
January 16, 2025
Via GlobeNewswire
Telix Exceeds FY24 Guidance with US$142M Q4 Revenue
January 13, 2025
Via GlobeNewswire
Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging
December 29, 2024
Via GlobeNewswire
Telix to Add FAP-Targeting Candidates to Theranostic Pipeline
November 18, 2024
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
Telix Pharmaceuticals Limited - American Depositary Shares (NQ:TLX)
9.340
-0.170
(-1.79%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 14, 2025
Add to My Watchlist
All News about Telix Pharmaceuticals Limited - American Depositary Shares
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|